https://www.energymonitor.ai/tech/geothermal-can-provide-hal...
2,308 karma · joined April 6, 2019
https://www.energymonitor.ai/tech/geothermal-can-provide-hal...
At the 7 year mark my cost per kwh will be below $0.02 . Power in my area (southwest US) is $0.12 per kwh. Some factors are complex to measure. Such as how much more I run the AC because it is essentially 'free' than I would if it were still $0.12 per kwh. Another complex factor is that I can generate much more power than I consume currently. If I found a sensible use for the surplus power then costs drop even lower even faster. My consumption is about 50% of max, on an annual basis.
As someone that has built and managed clinical laboratories for human samples, I find this article from consumer reports extremely misleading. The describe results as a percentage of a theoretically acceptable level. For example, for cadmium, they are saying an acceptable level is 4.1 ug/day . Then they seem to imply that "TJ The Dark Chocolate Lover's Chocolate 85% Cacao" has 229% of the 4.1ug/day if a consumer ate a 30g piece.
They never actually spell out what they mean or what the actual results they found were, or what the limit of detection of the methodology was or the error range of their tests. I guess they are saying that that chocolate has 9.3ug of cadmium in a 30g sample but it's impossible to say from what they wrote.
The FDA states that the maximum daily consumption of cadmium should be limited to 0.21-0.36ug per kg of body mass. For an avg american male that would mean a threshold of 17.64-30.24ug/day. A typical salad containing 250g of romaine lettuce has 2-14ug of cadmium in it. Lettuce and cereal grains are the most common sources of cadmium in american diets.
The amounts we are talking about are extraordinarily small and difficult to measure. We are talking 5-100 quadrillion individual atoms of cadmium.
https://article.images.consumerreports.org/image/upload/v167... https://www.fda.gov/food/environmental-contaminants-food/cad....
I have always had good experiences with signature solar. My inverters are EG4 and I am very happy with their product after trying A LOT of others. I think the primary reasons for the price difference is that you are purchasing US inventory (it's already here), it's preassembled and warrantied as a unit, they provide pretty decent support and their battery packs use 100ah cells instead of 280ah+ cells. So you are buying ~3x as many BMSs, connecting cable ($$$$) and cases for the same power.
Their rackable units are not light but can be moved by a capable person without too much fuss. A fully loaded 280ah unit in it's case is over 250lb so you really need a lift cart or such. The 280ah units and now maybe 320ah are more economical.
From the same suppliers sodium batteries are currently $130/kwh and about 26% less efficient in the same form factor. I look forward to this changing.
Due to rising power costs I moved one of my homes completely to solar and battery (lifepo4) and haven't had any problems. I can't imagine ever going back to the power company. Panels have gotten to the point of being ridiculously cheap. I have a lot of space. I purchased pallets of used panels for more or less the cost of transportation ($34 per panel 270w). They produce about 85% of their nominal rating.
I mention this because other comments mention costs that are much much higher.
At the start of the pandemic, the general unavailability of mainstream supply chain covid testing apparatus combined with an absolute torrent of cash, somewhere around 900 billion in total overall, created a cottage industry in covid testing startups. At the time the institutional thinking was that this was "a good thing" because existing infrastructure had a 0% of meeting covid testing demand. The FDA and other regulators more or less abandoned what little oversight of lab developed tests (LDT) there was during this period. They remain lightly regulated. Fast forward to today, a large number of the covid testing startups still exist and are sitting on mountains of cash, having come up in the age of LDTs they are going to continue to min/max that shaky regulatory framework. People in the startup sphere of influence constantly complain about the FDA being too involved in regulation. LDTs will lead to innovations as well as a abuses, I predict many people will complain their regulation is too lax. Such is the way of trying to regulate anything in healthcare.
One of the most obvious signs you are in a well managed health system is seeing copper/brassy touch surfaces instead of stainless.
https://www.copper.org/publications/newsletters/ba-news/2010... https://en.wikipedia.org/wiki/Antimicrobial_properties_of_co... https://www.statnews.com/2020/09/24/as-hospitals-look-to-pre...
Up until 2012 even, most CDC reporting was done as manual chart reviews typed into an excel sheet. That was a very error prone process.
One of the few times in managing hospital systems I was actually shocked at unethical behavior was when we took over management of a system that through accidents of history included a series of dentistry clinics. Dentists do not have any equivalent to a hippocratic oath, they have no professional obligation to be honest with their "patients". The overriding operational theme of the clinics was how to defraud "patients" with completely unecessary work to maximize profits and borderline defraud dental insurance. I understand that people have a dim view of ethics in american healthcare but this was what I would consider criminal behavior in a medical setting but as further experiences taught me, is the norm in american dentistry. Suffice it to say that we divested from the dentistry clinics asap.
Here is one swiss study showing that 30% of dentists committed fraud in the studed visits or were so incompetent that their behavior constituted fraud. I would guess that american dentistry is closer to 50%.
Have you had your wisdom teeth out? You are very likely to be the victim of dental fraud.
I advise a lot of health related startups. I think the list is OK but the two most important things I have seen come up over and over again are 'have a show pony' and KISS.
"Have a show pony" means you need to have a doctor associated with your business, idea, etc that is high profile and a public advocate for it. Doesn't necessarily mean as an employee or consultant, etc, that can get complex because of corporate practice of medicine regulations but advisory boards and research partners are often good fits. This lets you be taken seriously by what are extremely risk averse institutions in most cases, especially when dealing with "two guys and a hard drive" startups.
KISS is the old adage, keep it simple stupid, but really in healthcare the overwhelming high priority problems are insanely simple people issues. Getting people to wash their hands, getting patients to show up at the right time and the right place, having an organized and non-duplicative flow of operating information. A tremendous amount of healthcare is done via spreadsheet, think at that level. Complex solutions can be profitable but almost never endure and can be extremely hard to sell.
I think a lot can be gleaned about the general dysfuction of healthcare as an industry from this previous HN thread: https://news.ycombinator.com/item?id=39186252
I think the comparison to thalidomide is click bait. Thalidomide was such a problem because it was used to treat symptoms of pregnancy, not some other unrelated condition. In this situation all(?) of the first line pharmaceutical treatments for managing epileptic seizures pose at least some developmental risk to unborn children. On the other hand unmanaged epileptic seizures also pose a risk to the parent and child.
This was a situation of gross negligence on the part of the institutions involved in regulation AND the direct providers offering care. A classic "somebody else's problem" field. Institutions failed to identify the actual scale of the risks involved in a way that properly educated providers and providers chose an inappropriate framework with which to manage and communicate the risks to patients who could or did become pregnant.
The drug involved here is not really the problem, it is an effective drug at managing epileptic seizures. A reasonable approach that was not employed would be to properly identify the drugs serious dangers to developing children in those who may become pregnant to providers. As a regulator you need to hit them over the head with it. From a course of treatment standpoint selection of alternative drugs for patients who would like to become pregnant that have slightly less risk to undeveloped children need to be prioritized. Providers need to make sure that proper supplementation happens (folic acid, etc). The risk is meaningfully reduced and the patient would better understand what can happen. This type of comprehensive and nuanced course of treatment is something that is just very very difficult for healthcare, in the US anyway, to achieve.
It took us 10 years to really get the hang of how to create positive operational change in big healthcare systems and it's very nuanced and slow. In a nutshell it's a lot of carrot and stick or maybe a lot of micro-carrot and micro-stick.
Amazon tried the brute force approach with Haven and it failed spectacularly. The pharmacy and one-medical plays were a dip your toes in the water approach but from what I have seen they are replaying most of the same mistakes.